147 related articles for article (PubMed ID: 37585669)
1. Deciphering the Inhibitory Mechanism of Naphthoquinone-Dopamine on the Aggregation of Tau Core Fragments PHF6* and PHF6.
Zou Y; Qi B; Tan J; Guan L; Zhang Q; Sun Y; Huang F
ACS Chem Neurosci; 2023 Sep; 14(17):3265-3277. PubMed ID: 37585669
[TBL] [Abstract][Full Text] [Related]
2. Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6.
Zou Y; Guan L; Tan J; Qi B; Wang Y; Zhang Q; Sun Y
J Phys Chem B; 2023 Jan; 127(1):335-345. PubMed ID: 36594671
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone-Dopamine hybrid.
Paul A; Viswanathan GK; Huber A; Arad E; Engel H; Jelinek R; Gazit E; Segal D
FEBS J; 2021 Jul; 288(14):4267-4290. PubMed ID: 33523571
[TBL] [Abstract][Full Text] [Related]
4. Naphthoquinone-dopamine hybrids disrupt α-synuclein fibrils by their intramolecular synergistic interactions with fibrils and display a better effect on fibril disruption.
Zhou Y; Yao Y; Yang Z; Tang Y; Wei G
Phys Chem Chem Phys; 2023 May; 25(20):14471-14483. PubMed ID: 37190853
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the co-aggregation of Aβ and tau amyloid core peptides: Revealing potential pathological heterooligomers by simulations.
Li X; Chen Y; Yang Z; Zhang S; Wei G; Zhang L
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127841. PubMed ID: 37924907
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Role of ATP on PHF6 Aggregation.
Pal S; Roy R; Paul S
J Phys Chem B; 2022 Jul; 126(26):4761-4775. PubMed ID: 35759245
[TBL] [Abstract][Full Text] [Related]
7. On the Tracks of the Aggregation Mechanism of the PHF6 Peptide from Tau Protein: Molecular Dynamics, Energy, and Interaction Network Investigations.
Fagnen C; Giovannini J; Catto M; Voisin-Chiret AS; Sopkova-de Oliveira Santos J
ACS Chem Neurosci; 2022 Oct; 13(19):2874-2887. PubMed ID: 36153969
[TBL] [Abstract][Full Text] [Related]
8. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations reveal the disruption mechanism of a 2,4-thiazolidinedione derivative C30 against tau hexapeptide (PHF6) oligomer.
Liu H; Zhong H; Liu H; Yao X
Proteins; 2022 Jan; 90(1):142-154. PubMed ID: 34331342
[TBL] [Abstract][Full Text] [Related]
10. Identification of Aggregation Mechanism of Acetylated PHF6* and PHF6 Tau Peptides Based on Molecular Dynamics Simulations and Markov State Modeling.
Shah SJA; Zhang Q; Guo J; Liu H; Liu H; Villà-Freixa J
ACS Chem Neurosci; 2023 Nov; 14(21):3959-3971. PubMed ID: 37830541
[TBL] [Abstract][Full Text] [Related]
11. Molecular Insights into the Differential Effects of Acetylation on the Aggregation of Tau Microtubule-Binding Repeats.
Zou Y; Guan L; Tan J; Qi B; Sun Y; Huang F; Zhang Q
J Chem Inf Model; 2024 Apr; 64(8):3386-3399. PubMed ID: 38489841
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the Influence of K280 Acetylation on the Conformational Features of Tau Core Fragment: A Molecular Dynamics Simulation Study.
Zou Y; Guan L
Front Mol Biosci; 2021; 8():801577. PubMed ID: 34966788
[TBL] [Abstract][Full Text] [Related]
13. Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of PHF6 Peptide of Tau Protein.
Man VH; He X; Gao J; Wang J
J Chem Theory Comput; 2021 Oct; 17(10):6458-6471. PubMed ID: 34491058
[TBL] [Abstract][Full Text] [Related]
14. Potent Tau Aggregation Inhibitor D-Peptides Selected against Tau-Repeat 2 Using Mirror Image Phage Display.
Malhis M; Kaniyappan S; Aillaud I; Chandupatla RR; Ramirez LM; Zweckstetter M; Horn AHC; Mandelkow E; Sticht H; Funke SA
Chembiochem; 2021 Nov; 22(21):3049-3059. PubMed ID: 34375027
[TBL] [Abstract][Full Text] [Related]
15. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; Gosselet F; Gazit E; Segal D
Cell Mol Life Sci; 2020 Jul; 77(14):2795-2813. PubMed ID: 31562564
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Insight into the Mechanisms of Dopamine in Disrupting Aβ Protofibrils and Inhibiting Aβ Aggregation.
Chen Y; Li X; Zhan C; Lao Z; Li F; Dong X; Wei G
ACS Chem Neurosci; 2021 Nov; 12(21):4007-4019. PubMed ID: 34472835
[TBL] [Abstract][Full Text] [Related]
17. Inhibitive and Destructive Mechanisms of Chronic Traumatic Encephalopathy-Related R3-R4 Tau Peptide Chains and Protofibril by Epigallocatechin Gallate: Evidence from Molecular Dynamics Simulation.
Tang J; Sun R; Wan J; Xu Z; Gong Y; Zou Y; Zhang Q
ACS Chem Neurosci; 2023 Jun; 14(11):2098-2111. PubMed ID: 37213134
[TBL] [Abstract][Full Text] [Related]
18. Primary Fibril Nucleation of Aggregation Prone Tau Fragments PHF6 and PHF6.
Smit FX; Luiken JA; Bolhuis PG
J Phys Chem B; 2017 Apr; 121(15):3250-3261. PubMed ID: 27776213
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes.
Paul A; Viswanathan GK; Mahapatra S; Balboni G; Pacifico S; Gazit E; Segal D
ACS Chem Neurosci; 2019 Aug; 10(8):3510-3520. PubMed ID: 31282646
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the effect of ALS mutation S375G on the conformational properties and aggregation dynamics of TDP-43
Xu Z; Zhang J; Tang J; Gong Y; Zou Y; Zhang Q
Biophys Chem; 2024 Jul; 310():107230. PubMed ID: 38615537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
